| Year |
Citation |
Score |
| 2016 |
Samir A, Bodor N, Imai T. Identification of esterase involved in the metabolism of two corticosteroid soft drugs. Biochemical Pharmacology. PMID 28017774 DOI: 10.1016/J.Bcp.2016.12.010 |
0.312 |
|
| 2016 |
Buchwald P, Bodor N. Brain-Targeting Chemical Delivery Systems and Their Cyclodextrin-Based Formulations in Light of the Contributions of Marcus E. Brewster. Journal of Pharmaceutical Sciences. PMID 27209462 DOI: 10.1016/J.Xphs.2016.04.007 |
0.371 |
|
| 2014 |
Buchwald P, Bodor N. Recent advances in the design and development of soft drugs Pharmazie. 69: 403-413. PMID 24974571 DOI: 10.1691/Ph.2014.3911R |
0.336 |
|
| 2013 |
Bodor N, Oshiro Y, Loftsson T, Katovich M, Caldwell W. Soft Drugs VI. The Application of the Inactive Metabolite Approach for Design of Soft β-Blockers1?2. Pharmaceutical Research. 1: 120-5. PMID 24277248 DOI: 10.1023/A:1016376003515 |
0.345 |
|
| 2010 |
Bodor N, Buchwald P. Retrometabolism‐Based Drug Design and Targeting Burger's Medicinal Chemistry and Drug Discovery. 73-190. DOI: 10.1002/0471266949.Bmc035.Pub2 |
0.387 |
|
| 2008 |
Park H, Shin Y, Park S, Wu J, Bodor N, Yoon S. Selective Reduction of Trigonellyl Group to the Corresponding Dihydropyridine in the Presence of Disulfide Group Bulletin of the Korean Chemical Society. 29: 479-482. DOI: 10.5012/Bkcs.2008.29.2.479 |
0.318 |
|
| 2008 |
Bodor N, Buchwald P. Retrometabolic drug design: Principles and recent developments Pure and Applied Chemistry. 80: 1669-1682. DOI: 10.1351/Pac200880081669 |
0.377 |
|
| 2006 |
Ji F, Wu W, Dai X, Mori N, Wu J, Buchwald P, Bodor N. Synthesis and pharmacological effects of new, N-substituted soft anticholinergics based on glycopyrrolate. The Journal of Pharmacy and Pharmacology. 57: 1427-35. PMID 16259775 DOI: 10.1211/Jpp.57.11.0008 |
0.344 |
|
| 2006 |
Bodor N, Buchwald P. Brain-targeted delivery of estradiol: Therapeutic potential and results obtained with a chemical delivery system approach American Journal of Drug Delivery. 4: 161-175. DOI: 10.2165/00137696-200604030-00004 |
0.343 |
|
| 2005 |
Bodor N, Buchwald P. Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems. The Aaps Journal. 7: E820-33. PMID 16594634 DOI: 10.1208/Aapsj070479 |
0.347 |
|
| 2004 |
Bodor N, Buchwald P. Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites. Molecular Biotechnology. 26: 123-32. PMID 14764938 DOI: 10.1385/Mb:26:2:123 |
0.327 |
|
| 2003 |
Bodor N, Buchwald P. Brain-Targeted Drug Delivery American Journal of Drug Delivery. 1: 13-26. DOI: 10.2165/00137696-200301010-00002 |
0.324 |
|
| 2002 |
Bodor N, Buchwald P. Barriers to remember: brain-targeting chemical delivery systems and Alzheimer's disease. Drug Discovery Today. 7: 766-74. PMID 12547033 DOI: 10.1016/S1359-6446(02)02332-2 |
0.369 |
|
| 2002 |
Wu J, Yoon SH, Wu WM, Bodor N. Synthesis and biological evaluations of brain-targeted chemical delivery systems of [Nva2]-TRH. The Journal of Pharmacy and Pharmacology. 54: 945-50. PMID 12162713 DOI: 10.1211/002235702760089063 |
0.355 |
|
| 2002 |
Bodor N, Buchwald P. Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites. Methods in Molecular Biology (Clifton, N.J.). 186: 301-12. PMID 12013781 DOI: 10.1385/1-59259-173-6:301 |
0.327 |
|
| 2002 |
Bodor N, Farag HH, Barros MD, Wu WM, Buchwald P. In vitro and in vivo evaluations of dihydroquinoline- and dihydroisoquinoline-based targetor moieties for brain-specific chemical delivery systems. Journal of Drug Targeting. 10: 63-71. PMID 11996088 DOI: 10.1080/10611860290007540 |
0.416 |
|
| 2002 |
Buchwald A, Derendorf H, Ji F, Nagaraja NY, Wu WM, Bodor N. Soft cannabinoid analogues as potential anti-glaucoma agents. Die Pharmazie. 57: 108-14. PMID 11878185 |
0.536 |
|
| 2002 |
Yoon S, Wu J, Bodor N. Synthesis and Brain Targeted Chemical Delivery of [Nva 2 , Pip 3 ]-TRH Bulletin of the Korean Chemical Society. 23: 761-764. DOI: 10.5012/Bkcs.2002.23.5.761 |
0.319 |
|
| 2002 |
Bodor N, Buchwald P. Theoretical insights into the formation, structure, and energetics of some cyclodextrin complexes Journal of Inclusion Phenomena. 44: 9-14. DOI: 10.1023/A:1023059016514 |
0.328 |
|
| 2001 |
Bodor N, Buchwald P. Drug targeting by retrometabolic design: Soft drugs and chemical delivery systems Journal of Receptor and Signal Transduction Research. 21: 287-310. PMID 11757686 DOI: 10.1081/Rrs-100107431 |
0.344 |
|
| 2000 |
Prokai L, Prokai-Tatrai K, Bodor N. Targeting drugs to the brain by redox chemical delivery systems Medicinal Research Reviews. 20: 367-416. PMID 10934349 DOI: 10.1002/1098-1128(200009)20:5<367::Aid-Med3>3.0.Co;2-P |
0.416 |
|
| 2000 |
Yoon SH, Wu J, Wu WM, Prokai L, Bodor N. Brain-targeted chemical delivery of [Leu2, Pip3]-TRH: Synthesis and biological evaluation Bioorganic and Medicinal Chemistry. 8: 1059-1063. PMID 10882017 DOI: 10.1016/S0968-0896(00)00043-2 |
0.317 |
|
| 2000 |
Hwang SK, Juhasz A, Yoon SH, Bodor N. Soft drugs. 12. Design, synthesis, and evaluation of soft bufuralol analogues. Journal of Medicinal Chemistry. 43: 1525-32. PMID 10780909 DOI: 10.1021/Jm9904654 |
0.353 |
|
| 2000 |
Buchwald A, Browne CE, Wu WM, Ji F, Bodor N. Soft cannabinoid analogues as potential anti-glaucoma agents. Die Pharmazie. 55: 196-201. PMID 10756540 |
0.599 |
|
| 2000 |
Bodor N, Buchwald P. Soft drug design: General principles and recent applications Medicinal Research Reviews. 20: 58-101. PMID 10608921 DOI: 10.1002/(Sici)1098-1128(200001)20:1<58::Aid-Med3>3.0.Co;2-X |
0.358 |
|
| 1999 |
Buchwald P, Bodor N. Quantitative structure-metabolism relationships: steric and nonsteric effects in the enzymatic hydrolysis of noncongener carboxylic esters. Journal of Medicinal Chemistry. 42: 5160-8. PMID 10602701 DOI: 10.1021/Jm990145K |
0.319 |
|
| 1999 |
Prokai L, Prokai-Tatrai K, Ouyang X, Kim HS, Wu WM, Zharikova A, Bodor N. Metabolism-based brain-targeting system for a thyrotropin-releasing hormone analogue Journal of Medicinal Chemistry. 42: 4563-4571. PMID 10579819 DOI: 10.1021/Jm980526I |
0.331 |
|
| 1999 |
Bodor N. Recent advances in retrometabolic design approaches Journal of Controlled Release. 62: 209-222. PMID 10518653 DOI: 10.1016/S0168-3659(99)00040-1 |
0.375 |
|
| 1999 |
Little RJ, Bodor N, Loftsson T. Soft drugs based on hydrocortisone: the inactive metabolite approach and its application to steroidal antiinflammatory agents. Pharmaceutical Research. 16: 961-7. PMID 10397621 DOI: 10.1023/A:1018907026460 |
0.345 |
|
| 1999 |
Bodor N, Buchwald P. Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems Advanced Drug Delivery Reviews. 36: 229-254. DOI: 10.1016/S0169-409X(98)00090-8 |
0.369 |
|
| 1998 |
Chen P, Bodor N, Wu WM, Prokai L. Strategies to target kyotorphin analogues to the brain Journal of Medicinal Chemistry. 41: 3773-3781. PMID 9748352 DOI: 10.1021/Jm970715L |
0.379 |
|
| 1998 |
Bodor N, Buchwald P, Huang MJ. Computer-assisted design of new drugs based on retrometabolic concepts. Sar and Qsar in Environmental Research. 8: 41-92. PMID 9517010 DOI: 10.1080/10629369808033261 |
0.379 |
|
| 1998 |
Somogyi G, Nishitani S, Nomi D, Buchwald P, Prokai L, Bodor N. Targeted drug delivery to the brain via phosphonate derivatives I. Design, synthesis and evaluation of an anionic chemical delivery system for testosterone International Journal of Pharmaceutics. 166: 15-26. DOI: 10.1016/S0378-5173(98)00025-8 |
0.391 |
|
| 1998 |
Somogyi G, Buchwald P, Nomi D, Prokai L, Bodor N. Targeted drug delivery to the brain via phosphonate derivatives II. Anionic chemical delivery system for zidovudine (AZT) International Journal of Pharmaceutics. 166: 27-35. DOI: 10.1016/S0378-5173(98)00012-X |
0.397 |
|
| 1998 |
Prokai L, Ouyang X, Prokai-Tatrai K, Simpkins JW, Bodor N. Synthesis and behavioral evaluation of a chemical brain-targeting system for a thyrotropin-releasing hormone analogue European Journal of Medicinal Chemistry. 33: 879-886. DOI: 10.1016/S0223-5234(99)80012-9 |
0.332 |
|
| 1998 |
Juh�sz A, Huang F, Ji F, Buchwald P, Wu WM, Bodor N. Design and evaluation of new soft anticholinergic agents Drug Development Research. 43: 117-127. DOI: 10.1002/(Sici)1098-2299(199802)43:2<117::Aid-Ddr5>3.0.Co;2-N |
0.384 |
|
| 1997 |
Bodor N, Buchwald P. Drug targeting via retrometabolic approaches Pharmacology and Therapeutics. 76: 1-27. PMID 9535166 DOI: 10.1016/S0163-7258(97)00098-3 |
0.362 |
|
| 1997 |
Bodor N, Farag HH, Somogyi G, Wu WM, Barros MDC, Prokai L. Ocular-specific delivery of timolol by sequential bioactivation of its oxime and methoxime analogs Journal of Ocular Pharmacology and Therapeutics. 13: 389-403. PMID 9326721 DOI: 10.1089/Jop.1997.13.389 |
0.332 |
|
| 1997 |
Kourounakis A, Bodor N, Simpkins J. Synthesis and evaluation of brain-targeted chemical delivery systems for the neurotrophomodulator 4-methylcatechol. The Journal of Pharmacy and Pharmacology. 49: 1-9. PMID 9120757 DOI: 10.1111/J.2042-7158.1997.Tb06742.X |
0.341 |
|
| 1997 |
Brewster ME, Anderson WR, Meinsma D, Moreno D, Webb AI, Pablo L, Estes KS, Derendorf H, Bodor N, Sawchuk R, Cheung B, Pop E. Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions. Journal of Pharmaceutical Sciences. 86: 335-9. PMID 9050802 DOI: 10.1021/Js9602913 |
0.308 |
|
| 1996 |
Prokai-Tatrai K, Prokai L, Bodor N. Brain-targeted delivery of a leucine-enkephalin analogue by retrometabolic design Journal of Medicinal Chemistry. 39: 4775-4782. PMID 8941392 DOI: 10.1021/Jm960356E |
0.342 |
|
| 1996 |
Brouillette G, Kawamura M, Kumar GN, Bodor N. Soft drugs. 21. Design and evaluation of soft analogs of propantheline. Journal of Pharmaceutical Sciences. 85: 619-23. PMID 8773959 DOI: 10.1021/Js950435Y |
0.381 |
|
| 1996 |
Saah M, Wu WM, Eberst K, Marvanyos E, Bodor N. Design, synthesis, and pharmacokinetic evaluation of a chemical delivery system for drug targeting to lung tissue. Journal of Pharmaceutical Sciences. 85: 496-504. PMID 8742941 DOI: 10.1021/Js9504200 |
0.382 |
|
| 1996 |
Kourounakis A, Bodor N, Simpkins J. Synthesis and evaluation of a brain-targeted catechol derivative as a potential NGF-inducer International Journal of Pharmaceutics. 141: 239-250. DOI: 10.1016/0378-5173(96)04642-X |
0.353 |
|
| 1995 |
Brewster ME, Anderson WR, Loftsson T, Huang MJ, Bodor N, Pop E. Preparation, characterization, and anesthetic properties of 2-hydroxypropyl-beta-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse. Journal of Pharmaceutical Sciences. 84: 1154-9. PMID 8801327 DOI: 10.1002/Jps.2600841004 |
0.319 |
|
| 1995 |
Bodor N, Prokai L, Wu WM, Somogyi G, Farag H. Sequential bioactivation of methoxime analogs of β-adrenergic antagonists in the eye Journal of Ocular Pharmacology and Therapeutics. 11: 305-318. PMID 8590263 DOI: 10.1089/Jop.1995.11.305 |
0.328 |
|
| 1995 |
Prokai L, Wu WM, Somogyi G, Bodor N. Ocular delivery of the β-adrenergic antagonist alprenolol by sequential bioactivation of its methoxime analogue Journal of Medicinal Chemistry. 38: 2018-2020. PMID 7783133 DOI: 10.1021/Jm00011A021 |
0.359 |
|
| 1995 |
Brewster ME, Druzgala PJ, Anderson WR, Huang MJ, Bodor N, Pop E. Efficacy of a 3-substituted versus 17-substituted chemical delivery system for estradiol brain targeting. Journal of Pharmaceutical Sciences. 84: 38-43. PMID 7714741 DOI: 10.1002/Jps.2600840110 |
0.384 |
|
| 1995 |
Yang HS, Wu WM, Bodor N. Soft drugs. XX. Design, synthesis, and evaluation of ultra-short acting beta-blockers. Pharmaceutical Research. 12: 329-36. PMID 7617516 DOI: 10.1023/A:1016283930696 |
0.35 |
|
| 1995 |
Brewster ME, Anderson WR, Helton DO, Bodor N, Pop E. Dose-dependent brain delivery of zidovudine through the use of a zidovudine chemical delivery system. Pharmaceutical Research. 12: 796-8. PMID 7479571 DOI: 10.1023/A:1016240432455 |
0.312 |
|
| 1995 |
Bodor N, Farag HH, Omar FA. Preparation, Preliminary Characterization and Complexation of a Crystalline Redox‐based Chemical Delivery System for Dopamine Pharmacy and Pharmacology Communications. 1: 301-306. DOI: 10.1111/J.2042-7158.1995.Tb00427.X |
0.32 |
|
| 1995 |
Brewster ME, Loftsson T, Amselem S, Friedmand D, Yogev A, Anderson WR, Helton DO, Dinculescu A, Bodor N, Pop E. Formulation development for a zidovudine chemical delivery system 1. Parenteral dosage forms International Journal of Pharmaceutics. 125: 17-30. DOI: 10.1016/0378-5173(95)00107-T |
0.368 |
|
| 1995 |
Bodor N. Retrometabolic drug design concepts in ophthalmic target-specific drug delivery Advanced Drug Delivery Reviews. 16: 21-38. DOI: 10.1016/0169-409X(95)00011-U |
0.358 |
|
| 1995 |
Pop E, Brewster ME, Huang M, Bodor N. Substituent effects on the stability of 1,4-dihydropyridines Journal of Molecular Structure: Theochem. 337: 49-55. DOI: 10.1016/0166-1280(94)04112-6 |
0.301 |
|
| 1995 |
Huang M, Doerge D, Bodor N, Pop E, Brewster ME. Nitrogen radical cations as intermediates in enzymatically mediated oxidative deaminations?application of molecular parametric models International Journal of Quantum Chemistry. 56: 171-179. DOI: 10.1002/Qua.560560718 |
0.3 |
|
| 1995 |
Brewster ME, Browne C, Bodor N, Pop E, Huang M, Balaban AT. Relative reactivity of 1,4- and 1,6-dihydronicotinic acid derivatives to radically mediated oxidation?a theoretical and experimental evaluation International Journal of Quantum Chemistry. 56: 161-170. DOI: 10.1002/Qua.560560717 |
0.305 |
|
| 1995 |
Pop E, Brewster ME, Huang M, Bodor N. Hydrolytic stability of allylic and phenolic esters of some synthetic cannabinoids: A theoretical (AM1) study International Journal of Quantum Chemistry. 56: 137-143. DOI: 10.1002/Qua.560560714 |
0.31 |
|
| 1995 |
Brewster ME, Huang M, Pop E, Bodor N. Isomeric interconversions in tamoxifen and related compounds: AnAM1 study International Journal of Quantum Chemistry. 53: 343-352. DOI: 10.1002/Qua.560530310 |
0.315 |
|
| 1994 |
Kumar G, Huang M, Hammer R, Bodor N. Soft Drugs. 17: Quantitative Structure-Activity Relationships of Soft Anticholinergics Based on Methatropine and Methscopolamine Journal of Pharmaceutical Sciences. 83: 117-118. PMID 8138901 DOI: 10.1002/Jps.2600830129 |
0.314 |
|
| 1994 |
Brewster ME, Bartruff MS, Anderson WR, Druzgala PJ, Bodor N, Pop E. Effect of molecular manipulation on the estrogenic activity of a brain-targeting estradiol chemical delivery system. Journal of Medicinal Chemistry. 37: 4237-44. PMID 7990122 DOI: 10.1021/Jm00050A020 |
0.325 |
|
| 1994 |
Bodor N. Designing safer ophthalmic drugs by soft drug approaches Journal of Ocular Pharmacology. 10: 3-15. PMID 7911503 DOI: 10.1089/Jop.1994.10.3 |
0.357 |
|
| 1994 |
Pop E, E. Brewster M, Pr楊ai-T�rai K, Bodor N. Novel Redox Derivatives of Tryptophan Heterocycles. 38: 2051. DOI: 10.3987/Com-94-6790 |
0.392 |
|
| 1994 |
Pop E, E. Brewster M, Dinculescu A, Huang M, Bodor N. Isomerism of Cephalosporin Esters; Theoretical and Practical Aspects Heterocycles. 37: 477. DOI: 10.3987/Com-93-S37 |
0.331 |
|
| 1994 |
Brewster ME, Braunstein AJ, Bartruff MSM, Kibbey C, Huang M, Pop E, Bodor N. Solubilization and electrochemical stabilization of substituted phenols through the use of 2-hydroxypropyl-β-cyclodextrin Supramolecular Chemistry. 4: 69-76. DOI: 10.1080/10610279408029864 |
0.311 |
|
| 1994 |
Simpkins JW, Bodor N. Enhanced Delivery of Steroids to the Brain Using a Redox-Based Chemical Delivery System Methods in Neurosciences. 22: 23-35. DOI: 10.1016/B978-0-12-185292-4.50008-5 |
0.371 |
|
| 1994 |
Loftsson T, Bodor N. The pharmacokinetics and transdermal delivery of loteprednol etabonate and related soft steroids Advanced Drug Delivery Reviews. 14: 293-299. DOI: 10.1016/0169-409X(94)90046-9 |
0.317 |
|
| 1994 |
Simpkins JW, Bodor N. The brain-targeted delivery of dopamine using a redox-based chemical delivery system Advanced Drug Delivery Reviews. 14: 243-249. DOI: 10.1016/0169-409X(94)90042-6 |
0.312 |
|
| 1994 |
Brewster M, Pop E, Huang M, Bodor N. Rotational barriers in phenol and sterically congested phenol derivatives, an AM1 study Journal of Molecular Structure: Theochem. 303: 25-38. DOI: 10.1016/0166-1280(94)80170-3 |
0.306 |
|
| 1994 |
Pop E, Huang M, Brewster ME, Bodor N. Stability of the 1,3-substituted 1,4-dihydropyridines: Substituent effects on the acid catalyzed hydration and oxidation reactions International Journal of Quantum Chemistry. 52: 173-180. DOI: 10.1002/Qua.560520713 |
0.326 |
|
| 1993 |
Brewster ME, Pop E, Braunstein AJ, Pop AC, Druzgala P, Dinculescu A, Anderson W, Elkoussi A, Bodor N. The effect of dihydronicotinate N-substitution on the brain-targeting efficacy of a zidovudine chemical delivery system. Pharmaceutical Research. 10: 1356-62. PMID 8234177 DOI: 10.1023/A:1018986217181 |
0.366 |
|
| 1993 |
Pop E, Liu ZZ, Vlasak J, Anderson W, Brewster ME, Bodor N. A Dihydroisoquinoline Targetor-Based Acid Resistant Chemical Delivery System of Azidothymidine (AZT) Drug Delivery. 1: 143-149. DOI: 10.3109/10717549309022769 |
0.359 |
|
| 1992 |
Druzgala P, Winwood D, Drewniak-Deyrup M, Smith S, Bodor N, Kaminski JJ. New water-soluble pilocarpine derivatives with enhanced and sustained muscarinic activity. Pharmaceutical Research. 9: 372-7. PMID 1614970 DOI: 10.1023/A:1015847103862 |
0.308 |
|
| 1992 |
Bodor N, Wu WM. A comparison of intraocular pressure elevating activity of loteprednol etabonate and dexamethasone in rabbits Current Eye Research. 11: 525-530. PMID 1505197 DOI: 10.3109/02713689209001808 |
0.3 |
|
| 1992 |
Hochhaus G, Chen LS, Ratka A, Druzgala P, Howes J, Bodor N, Derendorf H. Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs Journal of Pharmaceutical Sciences. 81: 1210-1215. PMID 1491342 DOI: 10.1002/Jps.2600811217 |
0.35 |
|
| 1992 |
Pop E, Bodor N. Chemical systems for delivery of antiepileptic drugs to the central nervous system. Epilepsy Research. 13: 1-16. PMID 1478193 DOI: 10.1016/0920-1211(92)90002-B |
0.401 |
|
| 1992 |
Bodor N, Loftsson T, Wu Wm. Metabolism, Distribution, and Transdermal Permeation of a Soft Corticosteroid, Loteprednol Etabonate Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 9: 1275-1278. PMID 1448425 DOI: 10.1023/A:1015849132396 |
0.319 |
|
| 1992 |
Raghavan K, Loftsson T, Brewster ME, Bodor N. Improved delivery through biological membranes. XLV. Synthesis, physical-chemical evaluation, and brain uptake studies of 2-chloroethyl nitrosourea delivery systems. Pharmaceutical Research. 9: 743-9. PMID 1409355 DOI: 10.1023/A:1015843219733 |
0.361 |
|
| 1992 |
Pop E, Anderson W, Vlasak J, Brewster ME, Bodor N. Enhanced brain delivery of 2′-fluoro-5-methylarabinosyluracil International Journal of Pharmaceutics. 84: 39-48. DOI: 10.1016/0378-5173(92)90213-L |
0.369 |
|
| 1992 |
Brewster ME, Loftsson T, Estes KS, Lin J, Fridriksdóttir H, Bodor N. Effect of various cyclodextrins on solution stability and dissolution rate of doxorubicin hydrochloride International Journal of Pharmaceutics. 79: 289-299. DOI: 10.1016/0378-5173(92)90121-H |
0.313 |
|
| 1992 |
Brewster ME, Huang MJ, Bodor N. Reactivity of biologically important reduced pyridines. Part 9. Effect of substitution on rotational energetics in 1-phenyl-1,4-dihydropyridine, the 1-phenylpyridinium cation and related systems Journal of Molecular Structure: Theochem. 257: 49-56. DOI: 10.1016/0166-1280(92)87179-4 |
0.312 |
|
| 1991 |
Prókai-Tátrai K, Pop E, Anderson W, Lin JL, Brewster ME, Bodor N. Redox derivatives of tranylcypromine: syntheses, properties, and monoamine oxidase inhibitor activity of some chemical delivery systems. Journal of Pharmaceutical Sciences. 80: 255-61. PMID 2051343 DOI: 10.1002/Jps.2600800313 |
0.398 |
|
| 1991 |
Druzgala P, Hochhaus G, Bodor N. Soft drugs-10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: Loteprednol etabonate Journal of Steroid Biochemistry and Molecular Biology. 38: 149-154. PMID 2004037 DOI: 10.1016/0960-0760(91)90120-T |
0.304 |
|
| 1991 |
Druzgala P, Wu WM, Bodor N. Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes Current Eye Research. 10: 933-937. PMID 1959381 DOI: 10.3109/02713689109020329 |
0.324 |
|
| 1991 |
Pop E, Loftsson T, Bodor N. Solubilization and stabilization of a benzylpenicillin chemical delivery system by 2-hydroxypropyl-beta-cyclodextrin. Pharmaceutical Research. 8: 1044-9. PMID 1924158 DOI: 10.1023/A:1015865209874 |
0.309 |
|
| 1991 |
Hammer RH, Wu W, Sastry JS, Bodor N. Short acting soft mydriatics Current Eye Research. 10: 565-570. PMID 1893772 DOI: 10.3109/02713689109001765 |
0.353 |
|
| 1991 |
Brewster ME, Anderson W, Bodor N. Brain, blood, and cerebrospinal fluid distribution of a zidovudine chemical delivery system in rabbits Journal of Pharmaceutical Sciences. 80: 843-846. PMID 1800706 DOI: 10.1002/Jps.2600800908 |
0.342 |
|
| 1991 |
Bodor N, Elkoussi A. Improved Delivery Through Biological Membranes. LVI. Pharmacological Evaluation of Alprenoxime—A New Potential Antiglaucoma Agent Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 8: 1389-1395. PMID 1798675 DOI: 10.1023/A:1015849123020 |
0.344 |
|
| 1991 |
Deyrup M, Sidwell R, Little R, Druzgala P, Bodor N, Brewster ME. Improved Delivery through Biological Membranes. Synthesis and Antiviral Activity of a Series of Ribavirin Chemical Delivery Systems: 2′ and 3′ Derivatives Antiviral Chemistry and Chemotherapy. 2: 337-355. DOI: 10.1177/095632029100200603 |
0.332 |
|
| 1991 |
Brewster ME, Deyrup M, Seyda K, Bodor N. Synthesis, characterization and in vitro evaluation of various sulfonamide chemical delivery systems International Journal of Pharmaceutics. 68: 215-229. DOI: 10.1016/0378-5173(91)90144-D |
0.388 |
|
| 1990 |
Pop E, Anderson W, Prókai-Tátrai K, Brewster ME, Fregly M, Bodor N. Antihypertensive activity of redox derivatives of tryptophan. Journal of Medicinal Chemistry. 33: 2216-21. PMID 2374148 DOI: 10.1021/Jm00170A028 |
0.381 |
|
| 1990 |
Pop E, Prókai-Tátrai K, Scott JD, Brewster ME, Bodor N. Application of a brain-targeting chemical delivery system to 9-amino-1,2,3,4-tetrahydroacridine. Pharmaceutical Research. 7: 658-64. PMID 2367335 DOI: 10.1023/A:1015886731991 |
0.382 |
|
| 1990 |
Rahimy MH, Simpkins JW, Bodor N. Dose and time-course evaluation of a redox-based estradiol-chemical delivery system for the brain. I. Tissue distribution. Pharmaceutical Research. 7: 1061-7. PMID 2281037 DOI: 10.1023/A:1015999318729 |
0.302 |
|
| 1990 |
Bodor N, Prokai L. Site- and Stereospecific Ocular Drug Delivery by Sequential Enzymatic Bioactivation Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 7: 723-725. PMID 1975690 DOI: 10.1023/A:1015863521513 |
0.367 |
|
| 1990 |
Wu WM, Pop E, Shek E, Bodor N. Improved delivery through biological membranes. 39. Brain-specific chemical delivery systems for 26-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats [Erratum to document cited in CA111(8):63813y] Journal of Medicinal Chemistry. 33: 880-880. DOI: 10.1021/Jm00164A066 |
0.332 |
|
| 1990 |
Brewster ME, kaminski JJ, Gabanyi Z, Czako K, Simay A, Bodor N. Reactivity of biologically important reduced pyridines VI. Lack of through-resonance stabilization in the ferricyanide-mediated oxidation of substituted 1-Phenyl-1,4-Dihydronicotinamides Tetrahedron. 46: 319-324. DOI: 10.1016/S0040-4020(01)85415-6 |
0.312 |
|
| 1989 |
Mullersman G, Derendorf H, Brewster ME, Estes KS, Bodor N. High-performance liquid chromatographic assay of a central nervous system (CNS)-directed estradiol chemical delivery system and its application after intravenous administration to rats. Pharmaceutical Research. 5: 172-7. PMID 3244629 DOI: 10.1023/A:1015964907110 |
0.327 |
|
| 1989 |
Brewster ME, Estes KS, Loftsson T, Perchalski R, Derendorf H, Mullersman G, Bodor N. Improved delivery through biological membranes. XXXL: Solubilization and stabilization of an estradiol chemical delivery system by modified beta-cyclodextrins. Journal of Pharmaceutical Sciences. 77: 981-5. PMID 3225761 DOI: 10.1002/Jps.2600771118 |
0.318 |
|
| 1989 |
Phelan MJ, Bodor N. Improved Delivery Through Biological Membranes. XXXVII. Synthesis and Stability of Novel Redox Derivatives of Naproxen and Indomethacin Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 6: 667-676. PMID 2813259 DOI: 10.1023/A:1015930220855 |
0.364 |
|
| 1989 |
Pop E, Wu WM, Bodor N. Chemical delivery systems for some penicillinase-resistant semisynthetic penicillins Journal of Medicinal Chemistry. 32: 1789-1795. PMID 2754706 DOI: 10.1021/Jm00128A021 |
0.35 |
|
| 1989 |
Wu WM, Pop E, Shek E, Bodor N. Improved delivery through biological membranes. 39. Brain-specific chemical delivery systems for .beta.-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats Journal of Medicinal Chemistry. 32: 1782-1788. PMID 2754705 DOI: 10.1021/Jm00128A020 |
0.348 |
|
| 1989 |
Pop E, Wu WM, Shek E, Bodor N. Brain-specific chemical delivery systems for beta-lactam antibiotics. Synthesis and properties of some dihydropyridine and dihydroiosquinoline derivatives of benzylpenicillin. Journal of Medicinal Chemistry. 32: 1774-1781. PMID 2754704 DOI: 10.1021/Jm00128A019 |
0.322 |
|
| 1989 |
Murakami T, Shek E, Pop E, Bodor N. Improved anticonvulsant activity of phenytoin by a redox brain delivery system. II: Stability in buffers and biological materials. Journal of Pharmaceutical Sciences. 78: 732-737. PMID 2585265 DOI: 10.1002/Jps.2600780906 |
0.369 |
|
| 1989 |
BODOR N, VENKATRAGHAVAN V, WINWOOD D, ESTES K, BREWSTER M. Improved delivery through biological membranes. XLI. Brain-enhanced delivery of chlorambucil International Journal of Pharmaceutics. 53: 195-208. DOI: 10.1016/0378-5173(89)90313-X |
0.382 |
|
| 1989 |
El-Koussi AA, Bodor N. Formation of propranolol in the iris-ciliary body from its propranolol ketoxime precursor - a potential antiglaucoma drug International Journal of Pharmaceutics. 53: 189-194. DOI: 10.1016/0378-5173(89)90312-8 |
0.352 |
|
| 1989 |
Pop E, Brewster ME, Kaminski JJ, Bodor N. Theoretical study of some heterocyclic amines with applications to the chemistry of 9-amino-1,2,3,4-tetrahydroacridine International Journal of Quantum Chemistry. 35: 315-324. DOI: 10.1002/Qua.560350208 |
0.366 |
|
| 1988 |
Bodor N, el-Koussi AA, Kano M, Khalifa MM. Soft drugs. 7. Soft beta-blockers for systemic and ophthalmic use. Journal of Medicinal Chemistry. 31: 1651-6. PMID 3398002 DOI: 10.1021/Jm00403A028 |
0.387 |
|
| 1988 |
Brewster ME, Estes KS, Perchalski R, Bodor N. A dihydropyridine conjugate which generates high and sustained levels of the corresponding pyridinium salt in the brain does not exhibit neurotoxicity in cynomolgus monkeys. Neuroscience Letters. 87: 277-82. PMID 3380349 DOI: 10.1016/0304-3940(88)90461-2 |
0.339 |
|
| 1988 |
Anderson WR, Simpkins JW, Brewster ME, Bodor N. Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol. Life Sciences. 42: 1493-502. PMID 3352462 DOI: 10.1016/0024-3205(88)90005-7 |
0.307 |
|
| 1988 |
Brewster ME, Estes KS, Bodor N. Improved delivery through biological membranes. 32. Synthesis and biological activity of brain-targeted delivery systems for various estradiol derivatives Journal of Medicinal Chemistry. 31: 244-249. PMID 3336022 DOI: 10.1021/Jm00396A038 |
0.397 |
|
| 1988 |
Anderson WR, Simpkins JW, Brewster ME, Bodor N. Effects of a brain-enhanced chemical delivery system for estradiol on body weight and serum hormones in middle-aged male rats. Endocrine Research. 14: 131-48. PMID 3168954 DOI: 10.3109/07435808809032982 |
0.312 |
|
| 1988 |
Bodor N, Elkoussi A. Novel 'soft' βblockers as potential safe antiglaucoma agents Current Eye Research. 7: 369-374. PMID 2897269 DOI: 10.3109/02713688809031786 |
0.352 |
|
| 1988 |
Bodor N, ElKoussi A, Kano M, Nakamura T. Improved delivery through biological membranes. 26. Design, synthesis, and pharmacological activity of a novel chemical delivery system for beta-adrenergic blocking agents. Journal of Medicinal Chemistry. 31: 100-106. PMID 2891852 DOI: 10.1021/Jm00396A015 |
0.31 |
|
| 1988 |
Bodor N, Kaminski JJ. Correlation between hydride transfer and one-electron oxidation of dihydropyridines and heterocycles Journal of Molecular Structure: Theochem. 163: 315-330. DOI: 10.1016/0166-1280(88)80398-1 |
0.339 |
|
| 1987 |
Bodor N. Redox drug delivery systems for targeting drugs to the brain Annals of the New York Academy of Sciences. 507: 289-306. PMID 2894793 DOI: 10.1111/J.1749-6632.1987.Tb45809.X |
0.351 |
|
| 1987 |
Bodor N, Kaminski JJ. Chapter 30 Prodrugs and Site-Specific Chemical Delivery Systems Annual Reports in Medicinal Chemistry. 22: 303-313. DOI: 10.1016/S0065-7743(08)61178-1 |
0.383 |
|
| 1987 |
Bodor N, McCornack J, Brewster ME. Improved delivery through biological membranes. XXII. Synthesis and distribution of brain-selective estrogen delivery systems International Journal of Pharmaceutics. 35: 47-59. DOI: 10.1016/0378-5173(87)90073-1 |
0.352 |
|
| 1986 |
Rand KH, Bodor N, el Koussi AA, Raad I, Miyake A, Houck H, Gildersleeve N. Potential treatment of herpes simplex virus encephalitis by brain-specific delivery of trifluorothymidine using a dihydropyridine in equilibrium pyridinium salt type redox delivery system. Journal of Medical Virology. 20: 1-8. PMID 3020165 DOI: 10.1002/Jmv.1890200102 |
0.357 |
|
| 1986 |
Bodor N, Abdelim AM. Improved delivery through biological membranes XX1: Nicotinamide ⇌ dihydronicotinamide based ester‐linked redox carrier systems Journal of Pharmaceutical Sciences. 75: 29-35. PMID 2937906 DOI: 10.1002/Jps.2600750108 |
0.379 |
|
| 1986 |
Brewster ME, Estes KS, Bodor N. Improved Delivery Through Biological Membranes. XXIV. Synthesis, in Vitro Studies, and in Vivo Characterization of Brain-Specific and Sustained Progestin Delivery Systems Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 3: 278-285. DOI: 10.1023/A:1016359301852 |
0.369 |
|
| 1986 |
Bodor N, Brewster ME. A MINDO/3 study of a substituted benzo[b] isoquinolizinium salt ⇆ benzo[b] quinolizine system Journal of Molecular Structure: Theochem. 138: 261-270. DOI: 10.1016/0166-1280(86)80018-5 |
0.35 |
|
| 1985 |
Simpkins JW, Bodor N, Enz A. Direct evidence for brain-specific release of dopamine from a redox delivery system. Journal of Pharmaceutical Sciences. 74: 1033-6. PMID 4078698 DOI: 10.1002/Jps.2600741002 |
0.349 |
|
| 1985 |
Bodor N, Abdelalim AM. Improved delivery through biological membranes XIX: Novel redox carriers for brain‐specific chemical delivery systems Journal of Pharmaceutical Sciences. 74: 241-245. PMID 4009430 DOI: 10.1002/Jps.2600740304 |
0.361 |
|
| 1984 |
Bodor N, Farag HH. Improved delivery through biological membranes XIV: Brain‐specific, sustained delivery of testosterone using a redox chemical delivery system Journal of Pharmaceutical Sciences. 73: 385-389. PMID 6716249 DOI: 10.1002/Jps.2600730324 |
0.341 |
|
| 1984 |
Bodor N. Soft drugs: Principles and methods for the design of safe drugs Medicinal Research Reviews. 4: 449-469. PMID 6387331 DOI: 10.1002/Med.2610040402 |
0.314 |
|
| 1984 |
Bodor N, Visor G. Improved Delivery Through Biological Membranes. XVII. A Site-Specific Chemical Delivery System as a Short-Acting Mydriatic Agent Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 1: 168-173. DOI: 10.1023/A:1016348624897 |
0.31 |
|
| 1984 |
LOFTSSON T, MATSUO M, CALDWELL R, GILDERSLEEVE N, BODOR N. Synthesis and evaluation of novel lidocaine sulfur analogs International Journal of Pharmaceutics. 22: 345-355. DOI: 10.1016/0378-5173(84)90035-8 |
0.338 |
|
| 1984 |
Bodor N. Techniques of Solubilization of Drugs. (Drugs and the Pharmaceutical Sciences Series, Vol 12.) Journal of Pharmaceutical Sciences. 73: 288. DOI: 10.1002/Jps.2600730245 |
0.301 |
|
| 1983 |
Bodor N, Farag HH. Improved delivery through biological membranes. 13.1 brain-specific delivery of dopamine with a dihydropyridine ⇌ pyridinium salt type redox delivery system Journal of Medicinal Chemistry. 26: 528-534. PMID 6834384 DOI: 10.1021/Jm00358A013 |
0.324 |
|
| 1983 |
Bodor N, Farag HH. Improved delivery through biological membranes. 11. A redox chemical drug-delivery system and its use for brain-specific delivery of phenylethylamine Journal of Medicinal Chemistry. 26: 313-318. PMID 6827552 DOI: 10.1002/Chin.198334197 |
0.392 |
|
| 1983 |
Bodor N, Sloan KB. Improved delivery through biological membranes. XII. The effect of the incorporation of biphasic solubilizing groups into prodrugs of steroids International Journal of Pharmaceutics. 15: 235-250. DOI: 10.1016/0378-5173(83)90158-8 |
0.338 |
|
| 1982 |
Bodor N, Farag HH, Brewster ME. Site-specific, sustained release of drugs to the brain. Science (New York, N.Y.). 214: 1370-2. PMID 7313698 DOI: 10.1126/Science.7313698 |
0.371 |
|
| 1982 |
Bodor N, Sloan KB. Soft drugs: Thiazolidine-type derivatives of progesterone and testosterone Journal of Pharmaceutical Sciences. 71: 514-520. PMID 7097495 DOI: 10.1002/Chin.198245341 |
0.356 |
|
| 1982 |
Bodor N, Brewster ME. Problems of delivery of drugs to the brain Pharmacology and Therapeutics. 19: 337-386. PMID 6765182 DOI: 10.1016/0163-7258(82)90073-0 |
0.321 |
|
| 1982 |
Bodor N, Sloan KB, Little RJ, Selk SH, Caldwell L. Soft drugs 4. 3-Spirothiazolidines of hydrocortisone and its derivatives International Journal of Pharmaceutics. 10: 307-321. DOI: 10.1016/0378-5173(82)90166-1 |
0.334 |
|
| 1982 |
Sloan KB, Bodor N. Hydroxymethyl and acyloxymethyl prodrugs of theophylline: enhanced delivery of polar drugs through skin International Journal of Pharmaceutics. 12: 299-313. DOI: 10.1016/0378-5173(82)90101-6 |
0.308 |
|
| 1982 |
Bodor N. Designing safer drugs based on the soft drug approach Trends in Pharmacological Sciences. 3: 53-56. DOI: 10.1016/0165-6147(82)91008-2 |
0.362 |
|
| 1981 |
Loftsson T, Bodor N. Improved delivery through biological membranes X: Percutaneous absorption and metabolism of methylsulfinylmethyl 2‐acetoxybenzoate and related aspirin prodrugs Journal of Pharmaceutical Sciences. 70: 756-758. PMID 7264920 DOI: 10.1002/Jps.2600700710 |
0.314 |
|
| 1981 |
Loftsson T, Kaminski JJ, Bodor N. Improved delivery through biological membranes VIII: Design, synthesis, and in vivo testing of true prodrugs of aspirin Journal of Pharmaceutical Sciences. 70: 743-749. PMID 7264918 DOI: 10.1002/Jps.2600700708 |
0.33 |
|
| 1980 |
Bodor N, Kaminski JJ. Soft drugs. 2. Soft alkylating compounds as potential antitumor agents Journal of Medicinal Chemistry. 23: 566-569. PMID 7381858 DOI: 10.1002/Chin.198038156 |
0.352 |
|
| 1980 |
Bodor N, Woods R, Raper C, Kearney P, Kaminski JJ. Soft drugs. 3. A new class of anticholinergic agents. Journal of Medicinal Chemistry. 23: 474-80. PMID 7381847 DOI: 10.1002/Chin.198038326 |
0.356 |
|
| 1980 |
Bodor N, Kaminski JJ, Selk S. Soft drugs: I. Labile quaternary ammonium salts as soft antimicrobials Journal of Medicinal Chemistry. 23: 469-474. PMID 7381846 DOI: 10.1021/Jm00179A001 |
0.359 |
|
| 1980 |
Bodor N, Kaminski JJ, Selk S. Soft drugs. 1. Labile quaternary ammonium salts as soft antimicrobials Journal of Medicinal Chemistry. 23: 470-474. DOI: 10.1002/Chin.198038212 |
0.318 |
|
| 1978 |
Bodor N, Sloan KB, Kuo YN, Higuchi T. Controlled delivery of theophylline: chemistry of 7-acyl- and 7,7'-acylditheophylline derivates. Journal of Pharmaceutical Sciences. 67: 1045-50. PMID 671234 DOI: 10.1002/Jps.2600670806 |
0.331 |
|
| 1978 |
Bodor N, Roller RG, Selk SJ. Elimination of a quaternary pyridinium salt delivered as its dihydropyridine derivative from brain of mice Journal of Pharmaceutical Sciences. 67: 685-687. PMID 641811 DOI: 10.1002/Jps.2600670531 |
0.328 |
|
| 1978 |
Bodor N, Pearlman R. Formation, stability, and protonation of dihydropyridines. A MINDO/3 study Journal of the American Chemical Society. 100: 4946-4953. DOI: 10.1021/Ja00484A004 |
0.3 |
|
| 1978 |
Bodor N, Kaminski JJ, Roller RG. Improved delivery through biological membranes VI. Potent sympathomimetic adrenalone derivatives International Journal of Pharmaceutics. 1: 189-196. DOI: 10.1016/0378-5173(78)90007-8 |
0.323 |
|
| 1977 |
Bodor N, Sloan KB, Higuchi T, Sasahara K. Improved delivery through biological membranes. 4. Prodrugs of L-Dopa Journal of Medicinal Chemistry. 20: 1435-1445. PMID 915903 DOI: 10.1002/Chin.197816148 |
0.304 |
|
| 1976 |
Kaminski JJ, Bodor N, Higuchi T. N‐halo derivatives III: Stabilization of nitrogen‐chlorine bond in N‐chloroamino acid derivatives Journal of Pharmaceutical Sciences. 65: 553-557. PMID 1271254 DOI: 10.1002/Jps.2600650418 |
0.312 |
|
| Show low-probability matches. |